Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases

Science Advances(2024)10.1126/sciadv.adq3539Source: DataRank Database

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases is a research paper published in Science Advances (2024). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

gen emdb uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 8.92)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Ye Zhou ORCID,Meltem Tatlı ORCID,Kevin Burbidge ORCID,Enquan Xu ORCID,Elizabeth Viverette ORCID

Live enrichment

PubMed:39485845 PMC:PMC11800946 OpenAlex:https://openalex.org/W4403969529

Swiss National Science Foundation

Grant: 188548

NINDS NIH HHS

Grant: RF1 NS109157

Intramural NIH HHS

Grant: ZIC ES043010

Swiss National Science Foundation

Grant: 310030

Intramural NIH HHS

Grant: ZIC ES103326

NINDS NIH HHS

Grant: R01 NS064934

National Institutes of Health

Grant: 1RF1NS109157-01

Examining the role of glycosphingolipids in the progression and heterogeneity of synucleinopathies

National Institutes of Health

Grant: 5R01NS064934-11

Mechanisms of LRRK2 Mediated Neurotoxicity

Swiss National Science Foundation

Grant: 64934

Castello di Serravalle: Eine archäologische Untersuchung.

FWCI

8.92

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1126/sciadv.adq3539

publisherhttps://doi.org/10.1126/sciadv.adq3539

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.adq3539

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39485845

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11800946

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsGenetic Neurodegenerative Diseases03 medical and health sciences0302 clinical medicine

MeSH Terms

AmyloidAnimalsBrainDisease Models, AnimalHumansMice, TransgenicModels, MolecularNeuronsParkinson DiseaseMultiple System AtrophyLewy Body DiseaseMicealpha-Synuclein

Keywords

FibrilLewy bodyAmyloid fibrilAlpha-synucleinCollagen fibrilChemistryCell biologyBiophysicsBiologyPathologyMedicineParkinson's diseaseDiseaseAmyloid βLewy Body DiseaseModels, MolecularNeuronsAmyloidBrainParkinson DiseaseMice, TransgenicMultiple System AtrophyMiceDisease Models, Animalalpha-Synuclein/metabolism; alpha-Synuclein/chemistry; Humans; Animals; Mice; Lewy Body Disease/metabolism; Lewy Body Disease/pathology; Parkinson Disease/metabolism; Parkinson Disease/pathology; Amyloid/metabolism; Amyloid/chemistry; Mice, Transgenic; Models, Molecular; Multiple System Atrophy/metabolism; Multiple System Atrophy/pathology; Disease Models, Animal; Neurons/metabolism; Neurons/pathology; Brain/metabolism; Brain/pathologyHumansAnimalsNeuroscience

Sustainable Development Goals

SDG 0: Good health and well-being